$1.22
0.043.39%
Últ. Act.: Oct 29, 4:01 PM
ALX Oncology Holdings (ALXO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.15 | $-0.16 | $-0.34 | $-0.37 |
| Actual | $-0.11 | $-0.15 | $-0.37 | $-0.36 |
| Surprise | +26.7% | +8.12% | -8.82% | +2.70% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.13 | $-0.14 | $-0.15 | $-0.17 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-0.11 | $-0.15 | 26.7 % |
| Q1 | May 8, 2026 | $-0.15 | $-0.16 | 8.12 % |
| Q4 | Feb 27, 2026 | $-0.37 | $-0.34 | -8.82 % |
| Q3 | Nov 7, 2025 | $-0.36 | $-0.37 | 2.70 % |